Changsha Duzheng Biotechnology Joint-stock Co., Ltd. was established in January 2016. It is a high-tech enterprise integrating "industry, academia, and research," focusing on providing digital and intelligent clinical research "one-stop" solutions and precision medicine services for global drugs (generic drugs, innovative drugs phases I-IV) and medical devices. The company is headquartered in Changsha, Hunan, with offices in multiple provinces. It currently has 750+ employees and approximately 8,000 square meters of office and laboratory space. Its main business includes: clinical research of generic drugs, improved new drugs, innovative drugs, and medical devices; medical writing/translation; clinical monitoring/auditing; SMO business; data management and statistical analysis; biological sample analysis; digital and intelligent product development and services for pharmaceutical R&D; biomarker detection and personalized medication consultation; in vivo drug and foreign substance concentration monitoring; and pharmacogenomics research. ● In the field of generic drugs, addressing the challenge of bioequivalence studies for "highly variable drugs," it proposed the "dynamic variability" control theory and successfully applied it in practice, leading the industry in this niche field. ● In the field of innovative drugs, it assisted China's first innovative drug based on pharmacogenomics to successfully launch. ● In the field of biomarkers, it discovered the world's first safety warning biomarker for traditional Chinese medicine: the HLA-B35:01 gene associated with susceptibility to liver injury caused by Polygonum multiflorum, providing a theoretical basis for the prevention and control of liver injury risks related to Polygonum multiflorum and its related preparations, which is of epoch-making significance. With the mission of "building a career to serve the country and sharing the nation's concerns," Duzheng Biology adheres to the core values of "innovation and pragmatism." Through full-process intelligent services, a strict quality control system, high-level innovative R&D capabilities, and high-quality social service resources, it continuously extends its industry and expands its regions, making positive contributions to the pharmaceutical cause of all humanity.
What does Changsha Duzheng Biotechnology Joint-stock Co., Ltd. require? Who is Duzheng Biology hiring? Duzheng Biology recruitment: 医疗卫生/美容保健类占比最多占46.7%，其次是销售类占35.1%. What education can get in at Duzheng Biology? 本科占比最多占70.1%，其次是硕士占17.1%. High education required at Duzheng Biology? 硕士占17.1%，博士占3.8%. Work experience required at Duzheng Biology? 1-3年占比最多占34.2%，其次是3-5年占27%. Where are the job locations at Duzheng Biology? 长沙占比最多占66.4%，其次是杭州占9%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
